Literature DB >> 9425039

Dynamic regulation of endothelial nitric oxide synthase: complementary roles of dual acylation and caveolin interactions.

O Feron1, J B Michel, K Sase, T Michel.   

Abstract

N-Terminal myristoylation and thiopalmitoylation of the endothelial isoform of nitric oxide synthase (eNOS) are required for targeting the enzyme to specialized signal-transducing microdomains of plasma membrane termed caveolae. We have previously documented that the subcellular localization of eNOS is dynamically regulated by agonists such as bradykinin, which promotes enzyme depalmitoylation and translocation from caveolae. More recently, we have shown that association of eNOS with caveolin, the principal structural protein in caveolae, leads to enzyme inhibition, in a reversible process modulated by Ca2+-calmodulin (CaM). We now report studies of the respective roles of acylation and caveolin interaction for regulating eNOS activity. Using eNOS truncation and deletion mutants expressed in COS-7 cells, we have identified an obligatory role for the N-terminal half of eNOS in stabilizing its association with caveolin. By exploring the differential effects of detergents (CHAPS vs octyl glucoside), we have shown that this direct interaction between both proteins is facilitated by, but does not require, eNOS acylation, and, importantly, that treatment of intact aortic endothelial cells with the calcium ionophore A23187 leads to the rapid disruption of the eNOS-caveolin complexes. Finally, using transiently transfected COS-7 cells, we have observed that the myristoylation-deficient cytosol-restricted eNOS mutant (myr-) as well as the cytosolic fraction of the palmitoylation-deficient eNOS mutant (palm-) may both interact with caveolin; this association also leads to a marked inhibition of enzyme activity, which is completely reversed by addition of calmodulin. We conclude that the regulatory eNOS-caveolin association is independent of the state of eNOS acylation, indicating that agonist-evoked Ca2+/CaM-dependent disruption of the caveolin-eNOS complex, rather than agonist-promoted depalmitoylation of eNOS, relieves caveolin's tonic inhibition of enzyme activity. We therefore propose that caveolin may serve as an eNOS chaperone regulating NO production independently of the enzyme's residence within caveolae or its state of acylation.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9425039     DOI: 10.1021/bi972307p

Source DB:  PubMed          Journal:  Biochemistry        ISSN: 0006-2960            Impact factor:   3.162


  32 in total

Review 1.  Caveolins, liquid-ordered domains, and signal transduction.

Authors:  E J Smart; G A Graf; M A McNiven; W C Sessa; J A Engelman; P E Scherer; T Okamoto; M P Lisanti
Journal:  Mol Cell Biol       Date:  1999-11       Impact factor: 4.272

2.  Dynamin mediates caveolar sequestration of muscarinic cholinergic receptors and alteration in NO signaling.

Authors:  C Dessy; R A Kelly; J L Balligand; O Feron
Journal:  EMBO J       Date:  2000-08-15       Impact factor: 11.598

3.  Inhibitors caveolin-1 and protein kinase G show differential subcellular colocalization with Nitric oxide synthase.

Authors:  T J Adebola; Raj Usha
Journal:  Afr Health Sci       Date:  2011-12       Impact factor: 0.927

4.  Platelet-endothelial cell adhesion molecule-1 regulates endothelial NO synthase activity and localization through signal transducers and activators of transcription 3-dependent NOSTRIN expression.

Authors:  Margaret E McCormick; Reema Goel; David Fulton; Stefanie Oess; Debra Newman; Ellie Tzima
Journal:  Arterioscler Thromb Vasc Biol       Date:  2010-12-23       Impact factor: 8.311

5.  Translocation of endothelial nitric-oxide synthase involves a ternary complex with caveolin-1 and NOSTRIN.

Authors:  Kirstin Schilling; Nils Opitz; Anja Wiesenthal; Stefanie Oess; Ritva Tikkanen; Werner Müller-Esterl; Ann Icking
Journal:  Mol Biol Cell       Date:  2006-06-28       Impact factor: 4.138

6.  Peptide-stimulation enhances compartmentalization and the catalytic activity of lung endothelial NOS.

Authors:  Tarun E Hutchinson; Sudeep Kuchibhotla; Edward R Block; Jawaharlal M Patel
Journal:  Cell Physiol Biochem       Date:  2009-11-04

7.  Plasma membrane calcium ATPase proteins as novel regulators of signal transduction pathways.

Authors:  Mary Louisa Holton; Weiguang Wang; Michael Emerson; Ludwig Neyses; Angel L Armesilla
Journal:  World J Biol Chem       Date:  2010-06-26

Review 8.  Nitric oxide signalling in cardiovascular health and disease.

Authors:  Charlotte Farah; Lauriane Y M Michel; Jean-Luc Balligand
Journal:  Nat Rev Cardiol       Date:  2018-02-01       Impact factor: 32.419

9.  Chronic β1-adrenergic blockade enhances myocardial β3-adrenergic coupling with nitric oxide-cGMP signaling in a canine model of chronic volume overload: new insight into mechanisms of cardiac benefit with selective β1-blocker therapy.

Authors:  Danielle M Trappanese; Yuchuan Liu; Ryan C McCormick; Alessandro Cannavo; Gayani Nanayakkara; Marina M Baskharoun; Harish Jarrett; Felix J Woitek; D Michael Tillson; A Ray Dillon; Fabio A Recchia; Jean-Luc Balligand; Steven R Houser; Walter J Koch; Louis J Dell'Italia; Emily J Tsai
Journal:  Basic Res Cardiol       Date:  2014-12-06       Impact factor: 17.165

10.  Endothelial function in aorta segments of apolipoprotein E-deficient mice before development of atherosclerotic lesions.

Authors:  Paul Fransen; Tim Van Assche; Pieter-Jan Guns; Cor E Van Hove; Gilles W De Keulenaer; Arnold G Herman; Hidde Bult
Journal:  Pflugers Arch       Date:  2007-09-27       Impact factor: 3.657

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.